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Abstract
Background: The human dopamine D4 receptor (DRD4) is a candidate gene of great interest in
molecular studies of human personality and psychiatric disorders. This gene is unique in having an
exceptionally high amount of polymorphic sites both in the coding and in the promoter region.
Results: We report the identification of a new 27 bp deletion starting 524 bp upstream of the
initiation codon (27 bp del) of the dopamine D4 receptor (DRD4) gene, in the close vicinity of the
-521C>T SNP. The presence of the 27 bp deletion leads to the misgenotyping of the -616C>G SNP
by the Sau96 I RFLP method, thus the genotype determination of the mutation is of additional
importance. The frequency of this novel sequence variation is considerably low (allele frequency is
= 0.16%), as no homozygotes, and only 3 heterozygote carriers were found in a healthy, unrelated
Caucasian sample (N = 955).
Conclusion: Remarkably, the deleted region contains consensus sequences of binding sites for
several known transcription factors, suggesting that the different alleles may affect the
transcriptional regulation of the gene. A comparison of methods and results for the allelic variations
of the DRD4 gene in various ethnic groups is also discussed, which has a high impact in psychiatric
genetic studies.
Background
The dopaminergic system has received a significant
amount of attention due to the important role it plays in
the central nervous system in motor control, cognition,
reward, emotion and endocrine regulation [1]. Recently,
the D4 dopamine receptor (DRD4) gene [Gen-
Bank:U95122, GenBank:L12397] has been the target of
psychogenetic studies mainly because it possesses a high
number of polymorphisms [2], presumably as a conse-
quence of its subtelomeric chromosomal localization
(11p15.5) [3,4]. Polymorphisms in the DRD4 gene have
received particular attention in the past decade because of
their possible role in mental disorders [5-8], substance
abuse [9-11] and the normal variations of human person-
ality [12-16].
The gene and its regulatory region contain several length
variations and numerous single nucleotide
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polymorphisms (SNPs). Much interest has been focused
on these sequence variants in the investigation of complex
neurobehavioral disorders using association study
methods.
However, results of the psychogenetic association studies
are often controversial. There are several reasons for the
lack of conclusive results, such as the dangers of popula-
tion stratification and the small effect size of individual
genes complicated by oligogenic interactions [17]. Failure
to confirm associations determined by various laborato-
ries is partially explained by differences in demographic
and ethnic structure of the subsequent studies, as a conse-
quence of the diversity in allele frequencies of several pol-
ymorphisms among different populations. Moreover,
differences in phenotyping and genotyping methodology
may also obscure the weak effect of a gene variant on the
investigated trait.
The human dopamine D4 receptor gene, located proximal
to the Harvey-RAS oncogene locus and distal to the tyro-
sine hydroxylase locus [18], consists of 4 exons. The third
exon contains a polymorphic 48 bp repeat region, the
repeat number varies between 2 and 11. This part of the
gene encodes the putative third cytoplasmic loop, and
thus the polymorphism changes the length of the receptor
protein [19]. Given that the variable number of 48 bp
repeat (VNTR) is in a region that couples to G proteins
and mediates postsynaptic effects [20], association studies
have generated considerable interest. The DRD4 VNTR
has been widely studied since a striking association was
described between the seven-repeat allele and the human
personality trait of increased novelty seeking [12,13],
although the replications of the initial findings have been
controversial [9,21]. So far evidence suggests that there is
an association between the DRD4 7 repeat allele and
attention deficit hyperactivity disorder (ADHD) also,
although the effect size is small [6].
Further polymorphisms of the coding region of the DRD4
gene were also identified, [5,22-24], moreover additional
mutations and polymorphisms have been described just
recently in the introns as well [25-27].
Analysis of the 5' upstream region of DRD4 gene revealed
that the promoter region is probably located in the region
between -591 and -123 relative to the initiation codon,
with a negative modulator between the -770 and -679
positions [28]. This region of the DRD4 gene is also aston-
ishingly abundant in polymorphisms (see Fig. 4), includ-
ing numerous SNPs [29,30], and a 120 bp tandem
duplication [31].
The -521C>T SNP is located on a CpG island at one end
of a cell-type specific regulatory element [28]. The -521C
allele was shown to be 40% more active than the T allele
in an in vitro transient expression system [32]. Moreover,
a significantly higher incidence of the CC genotype was
found among schizophrenics [32]. The SNP has also been
associated with novelty seeking behavior in separate stud-
ies of Japanese, Caucasian and Afro-American samples
[16,33,34], but negative results were also described [35-
37]. Meta-analyses of existing studies have been con-
ducted to provide statistical measures of the small associ-
ation between -521 C>T SNP genotypes and novelty
seeking [38].
Location of the 27 bp deletion and other polymorphic sites in the promoter region of the human DRD4 gene Figure 4
Location of the 27 bp deletion and other polymorphic sites in the promoter region of the human DRD4 gene. 
The deleted region starts 524 bp upstream of the initiation codon. Figure is drawn to scale and each position is shown relative 
to the first nucleotide of the initiation codon indicated as +1. A cell type-specific promoter region between -591 and -123 con-
tains the promoter of the gene, and the negative modulator is between the -770 and -679 positions (grey boxes). Open boxes 
indicate length variants at the DRD4 promoter region. Arrowheads specify the positions of SNPs.BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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A regularly investigated polymorphism in the promoter
sequence of the DRD4 gene is the -616C>G SNP that may
result in the gain of an AP-2 transcription factor binding
site [39] and thereby affects the expression characteristics
of the receptor. Associations of the -616C>G SNP with
ADHD [39,40], schizophrenia [41] and personality
dimensions [33] were studied but did not yield conse-
quent results. Barr et al.[39] added the -616C>G SNP to
the investigations of the 5' upstream region by studying
the haplotype transmissions of three polymorphisms in
the promoter region and the 48 bp VNTR in exon III as
genetic risk factors for ADHD. An association between
ADHD and the -616C>G SNP was reinforced recently
[40].
An additional length polymorphism of the 5' untranslated
region of the DRD4 gene has been reported as common in
the population. The polymorphism consists of a 120 bp
tandem duplication 1.2 kb upstream from the initiation
codon [31] and gives rise to the Pst  I RFLP previously
reported [42]. Association studies between the 120 bp
duplication and the occurrence of ADHD hypothesized
the potential significance of this region in the regulation
of transcription [43]. Experimental evidence suggests
enhanced binding capacity of Sp1 transcription element
to the duplicated form [44]. The duplication is abundant
in the human race, although allele frequencies do vary
among different ethnic groups (see Discussion).
Identification of new, perhaps functional length variants
is especially intriguing because the up-regulation of D4
receptors may be more significant than any changes in the
protein structure [45,46]. In previous publications the
density of DRD4 was found to be six fold elevated in the
brains of schizophrenic patients [47], and the DRD4
mRNA was elevated in the frontal cortex of schizophrenics
in post mortem studies in comparison with controls [47],
pointing to possible allelic variants that influence the
transcription levels of the DRD4 gene. The -521C>T SNP
has been shown to affect transcriptional activity in an in
vitro transient expression system [32]. In the present study
we characterized a new deletion mutation in the promoter
region of the DRD4 gene, which is a promising target of
future association studies. This sequence variation has
been discovered during the large-scale application of our
recently published Sau96 I RFLP genotyping method of
the -616C>G SNP [30]. A novel technique was developed
for the screening of this mutation, and applied on a Cau-
casian (Hungarian) population of 959 individuals.
Results
Recently, we described a novel genotyping method for the
analysis of the -616C>G SNP in the DRD4 gene [Gen-
Bank:L12397] promoter region [GenBank:U95122], con-
sisting of the Sau96 I RFLP and an allele specific
amplification procedure. The parallel application of the
two independent methods (referred to as double genotyp-
ing) highly increases the reliability of the study, especially
when investigating outstandingly polymorphic regions
such as the DRD4 gene [30]. During the large-scale geno-
typing of the -616C>G SNP by this newly described dou-
ble-genotyping method, we noticed some abnormalities
in the size of the produced fragments. Fig. (1) unmistaka-
bly shows the two different size fragments obtained from
the Sau96 I RFLP where the 207 bp long fragment repre-
sents the -616 C allele and the 172 bp long product refers
to the cleaved -616 G allele. Surprisingly, in lane 5, an
unexpected short fragment was produced (indicated by an
asterisk) in case of a sample having a -616 GG genotype
determined by allele-specific PCR [30] (not shown). The
size of the indefinite fragment was approximately 30 bp
less than that of the expected 172 bp long PCR product of
the -616 G allele. The appearance of the unusual PCR frag-
ment has two feasible explanations: (1) There might be a
new SNP in the amplified fragments of the sample result-
ing in an additional polymorphic Sau96 I restriction site,
(2) or a length variation in one of the alleles of the indi-
vidual might also be responsible for the production of the
short fragment. Electrophoretic analysis of the undigested
PCR-products yielded two distinct bands demonstrating
that the new sequence variant was a deletion.
When investigating the sample containing the deletion by
allele-specific amplification no abnormalities were found
(not shown). This can be readily explained focusing on
the setup of this method, which applies a sense C-specific
and an antisense G-specific primer for the simultaneous
amplification of two PCR-products with different length
corresponding to the two alleles respectively. Conse-
quently, if the new sequence variant is localized upstream
from the -616C>G SNP on the same chromosome as the -
616 C allele or downstream from the SNP together with
the G allele, then the deleted region is not amplified thus
the mutation does not show up on the electropherogram.
To confirm our notion we carried out the allele-specific
PCR of this sample applying primers with opposite orien-
tation (i.e. a sense G-and an antisense C-specific primer).
In this arrangement we detected a shortened -616 G spe-
cific PCR product, suggesting that the deletion is localized
downstream from the -616C>G SNP composing a haplo-
type with -616 G variant in this sample. Moreover, it is
important to note that the deletion does not cause any
uncertainty if the genotyping of the -616C>G SNP is car-
ried out by allele specific amplification, as the size differ-
ence between the two allele-specific products is fairly big
(252 bp) excluding the possibility of misgenotyping.
Sequencing of the shortened fragment of the Sau96 I RFLP
(referred to as the product of the "Del" allele) also con-
firmed the presence of the deletion in this sample. Fig. (2)BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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shows a sequence containing the deletion aligned to that
obtained from the GeneBank http://
www.ncbi.nlm.nih.gov: "Human dopamine D4 receptor
gene, 5' flanking region" (accession number: U95122)
and "Homo sapiens Dopamine D4 receptor (DRD4)
gene" (accession number: L12397). It is unambiguous
that the deletion affects 27 base-pairs, however its posi-
tion cannot be marked explicitly since it is located
between two GGAG sequences and it is hard to agree on
which GGAG is enclosed by the deleted section. Therefore
the mutation can be placed anywhere between the -524th
and the -554th positions relative to the initiation codon.
According to the nomenclature of the Human Genome
Variation Society http://www.hgvs.org/mutnomen/ we
suggest the -524 position to be the assigned start point of
the deletion, since this is the closest point to the coding
sequence of the DRD4 gene.
PCR primers flanking the region of the mutation were
designed (see "Methods") to determine the genotype of
the 27 bp deletion in our population of unrelated Cauca-
sians. Fig. (3) shows the electrophoretic separation of the
obtained PCR amplicons in the analysis of 5 samples. A
longer 391 bp (designated "Non-del") and a shorter 364
bp (referred to as "Del") fragment was formed in lane 3
representing a heterozygote for the 27 bp deletion ("Del"/
"Non-del"). The rest of the individuals (lanes 1, 2, 4 and
5) do not contain the deletion: only the longer fragment
was formed showing a homozygote "Non-del"/"Non-del"
genotype. In order to determine the allele frequency of
this new sequence variation, we screened for the Del allele
in a large (N = 955) healthy, unrelated Hungarian (Cau-
casian) population. Seeing that our results show a very
low allele frequency of 0.16% for the Del allele of the
DRD4 promoter region, this new variant can be consid-
ered as a mutation rather than a polymorphism. The Men-
delian inheritance of the novel 27 bp deletion was also
investigated by a three-generation family analysis, where
one heterozygote was found in the first and one in the sec-
ond generation, respectively. We did not find any
homozygotes in our sample population, or among the
available relatives (N = 4) of the heterozygote individuals.
To assign the functional role of the 27 bp deletion we car-
ried out an "in silico" transcription factor binding analysis.
The Transcription Element Search System (TESS; http://
Sau96 I RFLP genotyping method of the -616C>G SNP reveals a new variation in the DRD4 gene Figure 1
Sau96 I RFLP genotyping method of the -616C>G SNP reveals a new variation in the DRD4 gene. Representative 
genotyping results are depicted. Conditions of PCR amplification and electrophoretic separation were carried out as previously 
described (see Figure 2. in [30]). The asterisk indicates the short PCR fragment containing the deletion.BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
Page 5 of 12
(page number not for citation purposes)
www.cbil.upenn.edu/tess/) was used to specify the tran-
scription factors that can play a role in the gene expression
regulation by binding to this region. Even when applying
stringent search parameters (6 bases as "Minimum string
length" and allowing no mismatch in the sequence) the
following human transcription factors were suggested to
bind the region of investigation: NF-E2, AP-2, Sp1.
Although the physiological importance of this result
needs to be further studied, the presence of the Sp1 site is
especially notable, as a zinc finger type transcription fac-
tor (dopamine receptor regulating factor, DRRF) was
described to effectively bind to the same sequences as Sp1
in the dopamine receptor promoters [48].
Discussion
Here we described a novel 27 bp deletion in the DRD4
promoter region, which has several important aspects. Pri-
marily, it is a source of misgenotyping of the -616C>G
SNP when using the standard genotyping method of
Sau96 I RFLP. As this SNP is often studied in psychiatric
genetics finding the appropriate genotyping methodology
is of great importance [39,40]. The problem arises from
the hardly detectable difference between the 180 bp
amplicon of the 27 bp Del and the -616 C allele-combina-
tion (i.e. haplotype) vs. the 172 bp product of the -616 G
variant after Sau96 I digestion. Thus, the existence of such
a deletion is a source of error, since some of the -616 C
alleles might be misgenotyped as -616 G in the presence
of the deletion.
On the other hand, using the previously reported [30]
allele-specific amplification, it is possible to distinguish
between the -616C and G alleles with no doubt, even in
the presence of the deletion. We can explain the results
assuming that the four samples heterozygous for the dele-
tion contained the deleted allele on the same chromo-
some as the -616G allele. This assumption was later
confirmed by allele specific sequencing. As the -616C-spe-
cific primer was the sense and the -616G-specific primer
was the antisense primer in our system, the obtained
products did not contain the region of the deletion. When
applying a -616 G-specific sense primer in another setup
of allele specific amplification, the G-specific fragment
clearly showed the presence of the 27 bp deletion (data
Alignment of the deleted allele string with the published DNA sequence of the upstream region [GenBank:U95122,  GenBank:L12397] Figure 2
Alignment of the deleted allele string with the published DNA sequence of the upstream region [Gen-
Bank:U95122, GenBank:L12397.] Positions of the -616C>G, -615A>G, -603T>G, -602G>del and -521C>T SNPs are 
specified. The bold letters indicate the ambiguous localization of the deletion, however according to the nomenclature of the 
Human Genome Variation Society the suggested start point is the -524 position.BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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not shown), but the length variation did not influence the
accuracy of the -616C>G SNP genotyping after all.
Although the occurrence of the 27 bp deletion is rather
low (0.16%) in our healthy Caucasian population, the
allele frequency might be different in other ethnic groups
and various clinical samples. Therefore, further studies are
necessary to gather information on the allele and geno-
type frequencies of this novel length variant in a range of
other populations, and these results should be considered
in the psychogenetic association studies of the -616C>G
polymorphism as well.
It is of additional importance to perform association stud-
ies in different populations since each may represent
distinct environments that could possibly interact with
genetic variants. The methodological conditions and
demographic setting is crucial in evaluating the strength
of a relationship and in replicating an association found
by different investigations. Here we address the differ-
ences in ethnic structure and methodological approach
used in the successive studies of commonly investigated
DRD4 gene variations and review the diversity of their
allele frequencies in different populations around the
globe.
The variable number of a 48 bp repeat (48 bp VNTR) in
exon III makes the DRD4 gene one of the most frequently
studied genes in psychiatric genetics. The "long form"
(7R) of this length polymorphism was found to be associ-
ated with the personality trait of "novelty seeking"
[12,13], children's attention deficit hyperactivity syn-
drome [8] and drug abuse [10]. In the Hungarian popula-
tion (as well as in other Caucasian samples) the 4 repeat
allele occurs most frequently (65.0%), followed by the 7
repeat (19.5%) and the 2 repeat (8,9%) variations. The
rare alleles include the 3 repeat (3.8%), 8 repeat (1.2%), 5
repeat (1.1%) and the 6 repeat (0.4%) variants, whereas
no 9 and 11 repeat allele was found (see Table 1). We have
identified one 10 repeat allele (0.1%) in our large (2N =
1196) Caucasian sample. This form has only been
reported previously in the African population with 1%
incidence [49]. In numerous studies, genotype groups
were defined only by absence vs presence of the DRD4
exon III 7 repeat, these results are not included in the
table.
Genotyping the 27 bp deletion mutation in healthy Hungarian individuals Figure 3
Genotyping the 27 bp deletion mutation in healthy Hungarian individuals. Amplification conditions: reaction mix-
tures contained 200 µM dATP, dCTP, dTTP, and 100 µM dGTP and dITP; 1 µM of each primer (see Methods), 1 ng DNA tem-
plate, 0.25 U DNA polymerase, 1x reaction buffer, and 1x Q solution in a total volume of 10 µL. Thermocycling conditions: 
95°C for 15 min, followed by 35 cycles of 94°C for 1 min; 65°C for 30 sec; 72°C for 1 min, finished by 72°C for 10 min. Elec-
trophoresis: fine resolution agarose gel in 40 mM Tris, 10 mM EDTA pH 8.0 buffer solution at room temperature, 6.6 V/cm 
electric field, 90 min, followed by 1 µg/mL ethidium bromide staining. The faint diffuse bands in lane 3 migrating slower than the 
representative fragments presumably contain heteroduplex molecules.BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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The prevalence of the most common alleles in the Hun-
garian population studied matches the frequencies meas-
ured by Mill et al. (New Zeland [50]) and Strobel et al.
(Germany [51]). Minor differences of the 7 repeat
frequencies incidence among Caucasians might originate
from population stratification. If, however, allele
frequencies of similar populations are quite different this
problem might also originate from preferential amplifica-
tion of shorter PCR products [52] as a methodological
artifact in this highly GC rich region, resulting in an
underestimation of the 7 repeat allele frequencies in the
above populations.
Noticeably, there is considerable variation in the distribu-
tion of the alleles as we compare Caucasian and Asian
populations. The occurrence of the 7 repeat allele is
extremely low (0.5%) in Chinese and Japanese samples,
and relatively high in North American Mayans (39%),
whereas Caucasians have an intermediate (18.5%) mean
prevalence. There are two theories describing the origin of
the 7 repeat allele [53,54], however independently on the
reason for the varying frequency data of this variation, a
high danger of artifacts caused by population admixture
should definitely be taken into account when genetic
association studies are being performed [55].
Beside the length polymorphism of the DRD4 gene cod-
ing sequence, the 5' upstream region of this gene has
numerous sequence variations also. Among the promoter
polymorphisms, the -521C>T SNP has been widely
studied since it was shown to be associated with the per-
sonality trait of novelty seeking [16,34]. Frequency data
obtained for the -521C>T SNP seem to be considerably
constant among the populations (see Tab. 2), as
frequency differences between the ethnic groups are
smaller than the variations observed within the same
study group. Therefore, the alterations in the frequency
between the C vs. T alleles can be readily explained by the
differences in methodology and sample size. One of the
possible sources of technical difficulties might originate
from using the PCR-RFLP protocol designed by Okuyama
et al. [32], where the 3' end of the reverse primer anneals
to the polymorphic -603rd  position [41], -603T>del),
which might result in unequal amplification of the
homologous chromosomes in heterozygotes. Therefore
the position of the primers were changed in other proto-
cols, including the previously described PCR-RFLP sys-
tem, where an internal control restriction site was added
to the system [16]. In order to enhance the validity and
reliability, two parallel methods were used for genotyping
the -521C>T SNP in our laboratory, a PCR-RFLP and a fast
allele-specific protocol [56]. Using a large sample (N =
598), we found a somewhat lower (46.5%) allele fre-
quency for the -521 C allele compared to the -521 T allele
and the genotype frequencies corresponded to the Hardy-
Weinberg equilibrium (see Table 2., line 1).
Table 1: Allele frequency data for the 48 bp VNTR polymorphism of DRD4
Origin of populations Allele frequency (%)
2 N2345 678 1 0
Caucasian Hungarian (Ronai et al., 2000) 1196 8.9 3.8 65.0 1.1 0.4 19.5 1.2 0.1
European-mixed (Chang et al., 1996) 176 12.0 6.0 57.0 2.0 1.0 21.0 1.0 0.0
Caucasians in New Zealand (Mill et al., 2002) 1760 8.8 4.6 65.0 0.9 0.6 19.4 0.6 0.0
German (Strobel et al., 2003) 230 7.3 4.3 66.5 0.9 0.4 19.1 1.3 0.0
German (Franke et al., 2000) 394 7.1 3.3 70.1 3.3 0.5 15.2 0.5 0.0
Italian (Mochi et al., 2003) 212 10.4 3.3 68.9 2.8 0.9 13.2 0.5 0.0
Italian (DeLuca et al., 2003) 190 11.0 5.3 67.9 0.5 0.5 13.7 1.0 0.0
Mean 8.9 4.3 65.6 1.3 0.5 18.5 0.8 0.0
Standard deviation 1.1 0.6 2.5 0.8 0.2 2.1 0.3 0.0
Asian Chinese (Li et al., 2000) 608 18.8 1.2 76.6 1.3 2.1 0.0 0.0 0.0
Japanese (Ishiguro et al., 2000) 680 12.0 1.0 81.0 4.0 1.0 1.0 0.0 0.0
Mean 15.2 1.1 78.9 2.7 1.5 0.5 0.0 0.0
Standard deviation 3.4 0.1 2.2 1.3 0.5 0.5 0.0 0.0
African Falashan (Chang et al., 1996) 128 3.0 0.0 83.0 0.0 2.0 11.0 0.0 1.0
American Mayans (Chang et al., 1996) 100 1.0 0.0 57.0 0.0 3.0 39.0 0.0 0.0BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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Although the literature of the -616C>G SNP is limited, the
available genotype frequencies do vary among different
ethnic groups significantly as shown in Tab. (3). The fre-
quency of the two alleles were quite similar (-616C:
51.5%, -616G: 48.5%) in the Hungarian population stud-
ied, whereas in Asian and Afro-American populations a
higher occurrence of the -616G allele (69.7% and 71.8%
respectively) was observed. It is difficult to account for the
significant difference between the mixed-European and
the Hungarian samples. According to our recent results
[30], the Ava II RFLP genotyping protocol [29] overesti-
mated the -616C allele in the presence of the -615G allele
of a novel SNP in this position. Sau96 I, in place of the Ava
II restriction enzyme, was shown to be the appropriate
choice of restriction endonuclease [30], as the newly
described -615A>G SNP had no influence on the diges-
tion reaction by Sau96 I. This is another example of how
obtained allele frequencies depend on differences in
methodology, providing a source of unreplicated associa-
tion studies.
Recently, significant amount of interest has been focused
on a polymorphic tandem repeat element located 1.2 kb
upstream of the initiation codon in the DRD4 promoter.
The 120 bp of duplicated sequence was linked to ADHD
and might be involved in the regulation of transcription
[43,57]. Allele frequency variation is high among popula-
tions, in Europeans the duplicated form is more common
than in other populations (see Tab. 4). Since the region of
this length variation is not GC rich and it is further away
from the polymorphic hotspot of the DRD4 promoter, no
significant genotyping obstacles have been found.
Fig. (4) summarizes the polymorphisms highlighted by
the literature, and the number of the variants keeps
increasing. Some of the recently described polymor-
phisms such as the -1106C>T, -906C>T [27], -615A>G
[30] SNPs and the novel 27 bp deletion, described here
have not been characterized yet more thoroughly. The 27
bp deletion can be rapidly genotyped with the assay
described in this paper and could be a component of fur-
ther association studies that analyze the 5' region of the
DRD4 gene. Additionally, the dbSNP database of the
NCBI contains numerous further SNPs in the non-coding
region of the gene (-872A>G, -844C>G, -764A>C, -
754C>G, -713C>G, -599C>G, -528C>T, -364A>G) that
haven't even been published yet. Theoretical approaches
have shown that highly variable polymorphic markers are
more useful in association analysis than less polymorphic
ones, since there is a higher probability to identify allele
frequency differences between cases and controls [58].
Similarly, analysis of haplotypes, involving several poly-
morphic sites, might provide a greater power for associa-
tion analysis. Haplotypes of the 120 bp duplication [31]
and some of the SNPs [23,29] published earlier have
already been the targets of numerous genetic association
Table 2: Genotypes and allele frequencies of the -521 CT SNP in different populations
Origin of population Allele frequency (%) Genotype frequency (%)
2N C T N CC CT TT
Caucasian Hungarian (Szantai et al., 2005) 1196 46.5 53.5 598 21.4 50.0 28.6
European-mixed (Barr et al., 2001) 308 45.8 54.2 154
German (Strobel et al., 2003) 230 40.0 60.0 115 20.9 38.3 40.8
Swedish (Jönsson et al., 2001) 776 42.0 58.0 388 15.0 54.0 31.0
mean 44.4 55.6 19.1 50.2 30.7
Standard deviation 2.4 2.4 3.0 4.5 3.6
Asian Japanese (Okuyama et al., 1999) 538 41.0 59.0 269 14.0 53.0 33.0
Japanese (Ishiguro et al., 2000) 538 41.0 60.0 269 14.0 53.0 33.0
Japanese (Mitsuyasu et al., 1999) 294 41.0 59.0 147 17.9 46.3 35.8
Japanese (Okuyama et al., 2000) 172 53.5 46.5 86 32.5 41.9 25.6
Chinese (Xing et al., 2003) 412 39.1 60.9 206 12.1 53.9 34.0
Chinese (Li et al., 2000) 422 40.3 59.7 211 27.5 25.6 46.9
Korean (Lee et al., 2003) 202 46.0 54.0 101
mean 41.8 58.4 17.9 46.7 35.5
Standard deviation 3.5 3.6 6.7 10.4 5.8
American Afro-American (Bookman et al., 2002) 142 55.0 45.0 71 32.0 42.0 26.0BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
Page 9 of 12
(page number not for citation purposes)
studies. Recently, direct haplotype detection methods for
the commonly investigated -521C>T and -616C>G SNPs
as well as the 120 bp duplication promoter polymor-
phisms were developed in our laboratory [59,60]. Linkage
disequilibrium analysis of polymorphisms marks the
different haplotype blocks on the chromosome segment
giving way to future association studies [61].
The polymorphic variations in the regulatory region may
directly influence the regulation of transcription of the
DRD4 gene. It was demonstrated that some of these poly-
morphisms have functional effects resulting in different
transcriptional activity [32,57]. Furthermore, the 120 bp
duplication and the C to G change at the -616th position
cause the gain of additional binding sites of known tran-
Table 3: Allele and genotype frequencies of the -616 CG SNP in 5 populations
Origin of population Allele frequency (%) Genotype frequency (%)
2N C G N CC CG GG
Caucasian Hungarian (Szantai et al., 2005) 1196 51.5 48.5 598 27.8 47.5 24.7
European-mixed (Barr et al., 2001) 308 72.7 27.3 154
mean 55.8 44.2 31.1* 49.3* 19.5*
Standard deviation 8.6 8.6
Asian Japanese (Mitsuyasu et al., 1999) 160 28.4 71.6 80 14.9 26.9 58.2
Chinese (Xing et al., 2003) 412 31.1 68.9 206 6.3 49.5 44.2
mean 30.3 69.7 8.7 43.2 48.1
Standard deviation 1.2 1.2 3.9 10.1 6.3
American Afro-American (Bookman et al., 2002) 142 28.2 71.8 71 13.0 31.0 56.0
* Expected genotype frequencies were calculated from measured allele frequencies assuming Hardy-Weinberg equilibrium in the populations.
Table 4: Frequency distribution for the 120 bp duplicated alleles of the DRD4 promoter
Origin of population Allele frequency (%) Genotype frequency (%)
2N 1 2 N 1/1 1/2 2/2
Caucasian Hungarian (Szantai et al., 2005) 1196 17.1 82.9 598 3.0 28.3 68.7
European-mixed (Seaman et al., 1999) 174 19.5 80.5
European-mixed (Barr et al., 2001) 308 19.9 80.1
mean 17.9 82.1 3.2* 29.4* 67.4*
Standard deviation 1.5 1.5
Asian Chinese (Xing et al., 2003) 412 37.4 62.6 206 13.6 47.6 38.8
Chinese (Seaman et al., 1999) 122 36.1 63.9
mean 37.1 62.9 13.8* 46.6* 39.6*
Standard deviation 0.5 0.5
African African (Seaman et al., 1999) 136 59.6 40.4 35.5* 48.2* 16.3*
American Mayan (Seaman et al., 1999) 106 48.1 51.9 23.1* 49.9* 26.9*
* Expected genotype frequencies were calculated from measured allele frequencies assuming Hardy-Weinberg equilibrium in the populations.BMC Genetics 2005, 6:39 http://www.biomedcentral.com/1471-2156/6/39
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scription elements [31,39,62]. Accordingly, we examined
the deleted sequence for any potential transcriptional
binding sites and found the consensus sequences of sev-
eral factors, including Sp1, AP-2alphaB and NF-E2. It has
been reported in a human retinoblastoma cell line that
the -521C>T SNP has significant influence on the tran-
scriptional efficiency of the DRD4 gene suggesting the rel-
evance of a single SNP in dopaminergic
neurotransmission [32]. As the 27 bp deletion lies in the
very same region, it can be assumed that this variation
might also have a considerable impact on the transcrip-
tional activity of the gene.
Methods
Participants
DNA was extracted from epithelial cells of 959 healthy
subjects (396 male and 563 female) in a Caucasian sam-
ple of Hungarian origin. Signed informed consent was
obtained from all the participants. The research protocol
was approved by the Research Ethics Committee.
Non-invasive DNA sampling
Buccal cells were collected by cotton swabs from the inner
surface of the mouth [63]. DNA was isolated by phenol
extraction and alcohol precipitation as described earlier
[64].
Genotyping protocol for the 27 bp del
The Qiagen® HotStarTaq™ DNA polymerase kit was used
for polymerase chain reaction (PCR). Reaction mixtures
contained 200 µM dATP, dCTP, dTTP, and 100 µM dGTP
and dITP; 1 µM of forward primer (5'-GGA ATG GAG
GAG GGA GCG GG-3'), and 1 µM of reverse primer (5'-
GAC GCC AGC GCC ATC CTA CC-3'), approximately 1
ng DNA template, 0.25 U DNA polymerase, 1x reaction
buffer, and 1x Q solution in a total volume of 10 µL. Ther-
mocycling was initiated at 95°C for 15 minutes to activate
the hot start enzyme and to denature genomic DNA,
which was followed by 35 cycles of 1 min denaturation at
94°C, 30 sec annealing at 65°C and 1 min extension at
72°C. A final 10 min extension step at 72°C was followed
by cooling the samples to 8°C. PCR products were ana-
lyzed by conventional submarine horizontal agarose gel-
electrophoresis (MidiGel of Biocenter, Szeged, Hungary).
A composite gel was applied containing 1.5% low EEO
agarose Type I (Sigma Chemicals) and 2% Methaphor
agarose "fine resolution" (Cambrex Corporation). Separa-
tion was performed at room temperature in 40 mM Tris,
10 mM EDTA.Na2, 1% acetic acid (pH 8.0) buffer and 6.6
V/cm (100 V field strength, 26 mA) for 90 min. After sep-
aration, dsDNA fragments were stained in 1 µg/mL ethid-
ium bromide solution at room temperature for 15
minutes. No destaining was necessary. A BioRad Gel-Doc
1000 gel-documentation system (Hercules) was used for
visualization of the DNA fragments.
DNA sequencing
Genomic DNA of individuals shown to carry the deleted
allele were sequenced by amplification of the region in
question using the above described PCR conditions.
Polymerase chain reaction was carried out by the forward
primer: 5'-GGA ATG GAG GAG GGA GCG GG-3', and
reverse primer: 5'-CGC TCC ACC GTG AGC CCA GTA T-
3'. The shorter PCR product (deleted allele) was purified
from the gel using the Qiagen QIAquick Spin DNA-Extrac-
tion Kit. DNA sequencing was performed by an ABI 370
Sequencer, using the reverse primer (see above) of the
amplification reaction.
Database searching
The 27 bp of sequence, which is deleted in the mutant
allele, was searched for known transcription factor bind-
ing sites using the Transcription Element Search Software
(TESS) web-based search tool to search the TransFac data-
base; http://www.cbil.upenn.edu/tess[65].
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